Merit Medical Systems MMSI
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Merit Medical Systems (MMSI) Core Market Data and Business Metrics
Latest Closing Price
$105.45Price-Earnings Ratio
51.95Total Outstanding Shares
58.28 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
1600 West Merit Park Way, South Jordan, UT, 84095
Historical Stock Splits
If you bought 1 share of MMSI before August 15, 2003, you'd have 2.22 shares today.
| Execution Date | Split Amount |
|---|---|
| May 6, 2011 | 5-for-4 |
| December 3, 2003 | 4-for-3 |
| August 15, 2003 | 4-for-3 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-60.01 Million |
| Net Cash Flow, Continuing | $-207.86 Million |
| Net Cash Flow | $-207.86 Million |
| Net Cash Flow From Financing Activities | $-60.01 Million |
| Net Cash Flow From Investing Activities | $-368.65 Million |
| Net Cash Flow From Operating Activities, Continuing | $220.80 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $120.36 Million |
| Other Operating Expenses | $87.91 Million |
| Income Tax Expense/Benefit, Current | $44.51 Million |
| Basic Average Shares | $58.22 Million |
| Diluted Average Shares | $59.37 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $112.29 Million |
| Comprehensive Income/Loss | $112.29 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-8.07 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Long-term Debt | $729.55 Million |
| Assets | $2.42 Billion |
| Current Liabilities | $216.40 Million |
| Equity Attributable To Noncontrolling Interest | $0 |
| Liabilities And Equity | $2.42 Billion |
| Current Assets | $923.77 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||